etoposide has been researched along with Extranodal NK-T-Cell Lymphoma in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (13.85) | 29.6817 |
| 2010's | 44 (67.69) | 24.3611 |
| 2020's | 12 (18.46) | 2.80 |
| Authors | Studies |
|---|---|
| Amaki, J; Ando, T; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Hasegawa, M; Kagami, Y; Kameoka, Y; Katayama, N; Kubota, N; Maeda, T; Maruyama, D; Masaki, Y; Matsuoka, H; Miyazaki, K; Murayama, T; Oguchi, M; Sakai, R; Sekiguchi, N; Shimada, K; Suzuki, R; Taguchi, S; Takizawa, J; Terui, Y; Tsukamoto, H; Tsukamoto, N; Uoshima, N; Utsumi, T; Wada, H; Yamaguchi, M | 1 |
| Chen, X; Li, N; Luo, Q; Wu, W; Zou, L | 1 |
| Chang, Y; Feng, X; Fu, X; Li, L; Li, W; Li, X; Liu, X; Lu, Y; Nan, F; Shangguan, C; Shi, Y; Sun, Z; Wang, G; Wang, J; Wang, X; Wu, J; Wu, X; Xue, H; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X; Zhou, Z; Zou, L | 1 |
| Bai, B; Cai, Q; Gao, Y; He, H; He, Y; Huang, C; Huang, H; Huang, Y; Li, Z; Liu, Y; Pan, X; Ping, L; Wang, X; Zeng, W | 1 |
| He, ZD; Hong, HY; Li, MW; Peng, ZG; Xu, QY; Yang, HY | 1 |
| Chiattone, CS; Culler, HF; da Siqueira, SAC; de Oliveira Costa, R; de Pádua Covas Lage, LA; Machado, PPF; Miranda, E; Miyashiro, DR; Pereira, J; Reichert, CO; Rocha, V; Sanches, JA | 1 |
| Fu, R; Liang, Y; Liu, X; Piao, Y; Wang, L; Wei, L | 1 |
| Chen, X; Hai, T; Li, N; Luo, Q; Ren, K; Wu, W; Zhou, H; Zou, L | 1 |
| Carlos, R; Díaz Molina, JP; Paes de Almeida, O; Sánchez-Romero, C | 1 |
| Cao, J; Guo, Y; Hong, X; Jin, J; Liu, X; Liu, Y; Lv, F; Ma, X; Sun, H; Wang, J; Xia, Z; Xue, K; Zhang, Q | 1 |
| Cong, J; Li, X; Wang, J; Wang, L; Wei, L; Yang, J; Yang, L; Yao, N; Ye, J | 1 |
| Cong, J; Ding, J; Li, X; Wang, J; Wei, L; Yang, J; Yang, L; Yao, N; Ye, J | 1 |
| Deng, YT; Jiang, M; Jiang, Y; Liu, WP; Tian, R; Xie, L; Zhang, H; Zhang, L; Zhang, WY; Zhao, S; Zou, LQ | 1 |
| Cho, YS; Heo, DS; Jung, SH; Keam, B; Kim, DW; Kim, HJ; Kim, IH; Kim, M; Kim, TM; Lee, JY; Lee, SH; Ock, CY | 1 |
| Cao, S; Chen, B; Sui, X; Tang, F; Wang, S; Xu, C; Yin, L; Zhang, C; Zhi, X; Zhou, J | 1 |
| Fan, L; Li, JY; Liang, JH; Peter Gale, R; Wang, L; Wu, W; Xia, Y; Xu, W | 1 |
| Cai, G; Chen, JY; Cheng, S; Huang, HY; Wang, CF; Xiong, J; Xu, PP; Zhao, WL; Zhao, X; Zhong, HJ | 1 |
| Amaki, J; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Katayama, N; Kim, SJ; Kim, WS; Ko, YH; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Oguchi, M; Saito, B; Shimada, K; Shimoda, E; Soejima, T; Suzuki, R; Terui, Y; Tsukamoto, N; Utsumi, T; Yamaguchi, M | 1 |
| Fukuhara, S; Hatta, S; Ito, Y; Izutsu, K; Kim, SW; Maeshima, AM; Makita, S; Maruyama, D; Munakata, W; Suzuki, T; Watanabe, J; Yuda, S | 1 |
| Cao, JZ; Chen, B; He, X; Hou, XR; Lan, SM; Li, YX; Liu, X; Qi, SN; Qian, LT; Qu, BL; Shi, M; Su, H; Wang, Y; Wu, G; Wu, JX; Wu, T; Xu, LM; Yang, Y; Yuan, ZY; Zhang, FQ; Zhang, LL; Zhang, YJ; Zhu, SY; Zhu, Y | 1 |
| Bono, W; Bouayad, N; Bouhafa, T; Elmazghi, A; Khalid, H; Masbah, O; Oubelkacem, N | 1 |
| Jaffe, ES; Lucas, A; Melani, C; Pittaluga, S; Roschewski, M; Roswarski, J; Steinberg, SM; Waldmann, TA; Wilson, WH | 1 |
| Amaki, J; Ando, T; Asano, N; Kameoka, Y; Katayama, N; Kinoshita, S; Kobayashi, Y; Kubota, N; Maeda, T; Masaki, Y; Matsuoka, H; Miyazaki, K; Niitsu, N; Oguchi, M; Saito, B; Sakai, R; Sekiguchi, N; Suzuki, R; Takizawa, J; Tomita, N; Wada, H; Yamaguchi, M | 1 |
| Collins, G; Eyre, T; Hildyard, C; Sheikh, S | 1 |
| Chan, JK; Chan, KH; Kwong, YL; Pang, AW; So, JC | 1 |
| Díaz-Llopis, M; España-Gregori, E; Hernández-Martínez, P; Hervás-Ontiveros, A; Vera-Sempere, FJ | 1 |
| Lu, Y; Wang, L; Wang, WD; Xia, ZJ; Xiang, J; Zhang, YJ | 1 |
| Itani, K; Miyazaki, Y; Nagamatsu, K; Otsuka, E; Saburi, M; Saburi, Y; Urabe, S | 1 |
| Chang, H; Chen, X; Dai, Y; Dong, T; He, C; Ji, J; Li, J; Liu, T; Liu, W; Xiang, B | 1 |
| Chen, X; Li, S; Lu, Y; Wang, H; Wang, KF; Wang, Z; Wuxiao, ZJ; Xia, ZJ; Zhu, J | 1 |
| Choi, JY; Kang, ES; Kim, SJ; Kim, WS; Ko, YH; Lim, DH; Park, S | 1 |
| Heo, DS; Jeon, YK; Keam, B; Kim, CW; Kim, DW; Kim, KH; Kim, M; Kim, TM; Lee, JS; Lee, SH | 1 |
| Jiang, M; Jiang, Y; Wang, YQ; Yang, Y; Zhuo, HY; Zou, LQ | 1 |
| Chang, J; Ding, H; Hao, SG; Hu, D; Li, ZC; Liu, LG; Ma, LY; Ma, YJ; Tao, R; Yan, Y; Zhang, WH | 1 |
| Antosikova, A; Bosq, J; Carde, P; Chamseddine, AN; Danu, A; Dartigues, P; De Botton, S; Ferme, C; Ghez, D; Girinsky, T; Koscielny, S; Lazarovici, J; Mazeron, R; Michot, JM; Minard, V; Ribrag, V; Willekens, C | 1 |
| Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
| Ahn, YC; Kim, SJ; Kim, WS; Ko, YH; Oh, D | 1 |
| Dong, LH; Du, JW; Gao, X; Lei, W; Li, GP; Li, YF; Sun, X; Wang, WJ; Zhang, LJ | 1 |
| Carpten, JD; Cortes, D; Craig, D; Kirov, I; McEachron, TA; Sassoon, A; Sender, LS; Wungwattana, M; Zabokrtsky, KB | 1 |
| Chang, Y; Cui, Y; Fu, X; Li, L; Li, W; Li, X; Ma, W; Nan, F; Su, L; Sun, Z; Wang, J; Wang, X; Wu, J; Xue, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Cho, SH; Jung, KS; Kang, ES; Kim, SJ; Kim, WS; Ko, YH | 1 |
| Bae, SH; Eom, HS; Hong, J; Jeong, SH; Kang, HJ; Kim, SJ; Kim, WS; Kwak, JY; Lee, H; Lee, JH; Lee, MH; Park, SK; Shin, DY; Suh, C; Yang, DH; Yhim, HY; Yoon, DH | 1 |
| Bai, QX; Chen, JP; Chen, XQ; Dong, BX; Gao, GX; Gu, HT; Hao, CX; Liang, R; Shu, MM; Wang, JH; Wang, JS; Wang, XM; Yang, L; Zeng, Y; Zhang, N; Zhang, T | 1 |
| Ke, XY; Wan, WL; Wang, J; Zhang, W; Zhu, MX | 1 |
| Al Sa'ey, H; Al Shawabkeh, MA; Al Sulaiti, M; Ganesan, S | 1 |
| Akiba, T; Amaki, J; Ando, T; Asano, N; Ejima, Y; Hasegawa, M; Hyo, R; Ii, N; Itami, J; Itasaka, S; Katayama, N; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Murayama, T; Oguchi, M; Saito, B; Saito, Y; Sekiguchi, N; Suzuki, R; Takizawa, J; Tomita, N; Ueda, K; Wada, H; Yamaguchi, M | 1 |
| Celentano, A; Cirillo, N; De Rosa, G; Mascolo, M; Mignogna, MD | 1 |
| Akamatsu, N; Fujioka, Y; Fukuyama, M; Hasegawa, K; Hayashi, A; Ibaraki, T; Kokudo, N; Koya, J; Kurokawa, M; Mizuno, H; Nakamura, F; Shinozaki-Ushiku, A | 1 |
| Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, BS; Kim, CW; Kim, DW; Kim, NK; Kim, TY; Park, S; Yoon, SS | 1 |
| Yamaguchi, M | 2 |
| Katayama, N; Miyazaki, K; Monma, F; Nakase, K; Nishii, K; Tawara, I; Ueno, S; Yamaguchi, M | 1 |
| Deng, D; Huang, MJ; Li, M; Liu, WP; Wang, J; Xie, CH; Xu, Y; Zhang, XX; Zhao, YH; Zhou, L; Zou, BW | 1 |
| Kanemoto, M; Karahashi, T; Kato, T; Kobayashi, C; Morita, S; Tanabe, J | 1 |
| Hotta, T; Ishikura, S; Ishizawa, K; Ishizuka, N; Isobe, Y; Itoh, K; Kagami, Y; Kinoshita, T; Kobayashi, Y; Maseki, N; Matsuno, Y; Nawano, S; Oguchi, M; Ohshima, K; Oshimi, K; Terauchi, T; Tobinai, K; Usui, N; Wasada, I; Yamaguchi, M | 1 |
| Ahn, YC; Cho, J; Eom, HS; Huh, J; Kang, KM; Kim, BS; Kim, CY; Kim, JS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Lee, GW; Lee, SW; Pyo, HR; Suh, C | 1 |
| Arima, H; Imai, Y; Inoue, D; Kimura, T; Maruoka, H; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Nagano, S; Shimoji, S; Suzuki, R; Tabata, S; Takahashi, T; Takiuchi, Y; Togami, K; Yanagita, S | 1 |
| Suzuki, R | 1 |
| Cai, Q; Huang, H; Jiang, W; Lin, X; Lin, Z; Xia, Z | 1 |
| Heo, DS; Jang, JY; Jeon, YK; Kim, CW; Kim, TM; Kim, WY; Paik, JH | 1 |
| Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M | 1 |
| Chim, CS; Kim, SJ; Kim, WS; Kwong, YL; Leung, AY; Lim, ST; Tang, T; Tse, E | 1 |
| Hangaishi, A; Imai, Y; Kobayashi, T; Kurokawa, M; Morikawa, T; Nakamura, F; Ota, S; Shinohara, A; Takazawa, Y; Yamamoto, G | 1 |
| Hasegawa, Y; Izutsu, K; Kawa, K; Kim, WS; Kwong, YL; Nakamura, S; Okamura, T; Oshimi, K; Suzuki, R; Suzumiya, J; Yamaguchi, M | 1 |
| McMillan, A; O'Connor, S; Wills, AJ | 1 |
4 review(s) available for etoposide and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.
Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Methylprednisolone; Oxaliplatin | 2022 |
[Treatment of localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Glyoxal; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Peripheral Blood Stem Cell Transplantation; Prednimustine; Prednisolone; Prognosis; Radiotherapy; Vincristine | 2008 |
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Treatment Outcome | 2010 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinical Trials as Topic; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Neoplasm Staging; Nose Neoplasms | 2012 |
15 trial(s) available for etoposide and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lym
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Disease-Free Survival; DNA, Viral; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Survival Rate | 2017 |
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Prognosis | 2017 |
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine; Young Adult | 2019 |
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Skin Neoplasms; Steroids | 2019 |
Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Young Adult | 2015 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Young Adult | 2016 |
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Dexamethasone; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Conformal; Republic of Korea; Time Factors; Treatment Outcome | 2016 |
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; China; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Prognosis; Recurrence; Retreatment; Treatment Outcome; Young Adult | 2017 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prednisolone; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Japan; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nose Neoplasms; Probability; Proportional Hazards Models; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Risk Assessment; Sex Factors; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prospective Studies; Radiotherapy, Adjuvant; Republic of Korea; Risk Assessment; Time Factors; Treatment Outcome; Young Adult | 2009 |
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nausea; Neutropenia; Nose Neoplasms; Prednisone; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine; Vomiting | 2011 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult | 2012 |
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Ifosfamide; Leukemia, Lymphoid; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Middle Aged; Recurrence | 2008 |
46 other study(ies) available for etoposide and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; Dexamethasone; Etoposide; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2022 |
First-line LVDP (L-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Dexamethasone; Etoposide; Humans; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Neoplasm Staging; Retrospective Studies; Treatment Outcome | 2022 |
DDGP followed by radiotherapy vs VIPD followed by radiotherapy in newly diagnosed early NK/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Neoplasm Staging; Treatment Outcome | 2022 |
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Topics: Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, Peripheral; Retrospective Studies | 2023 |
High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.
Topics: Asparaginase; Brazil; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Retrospective Studies | 2022 |
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Neoplasm Staging; Treatment Outcome | 2023 |
Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Neoplasm Staging; Retrospective Studies; Treatment Outcome | 2023 |
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemoradiotherapy; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose; Nose Neoplasms; Skin Neoplasms | 2020 |
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Progression-Free Survival; Survival Analysis; Treatment Outcome | 2020 |
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Vindesine; Young Adult | 2020 |
Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Young Adult | 2021 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Escherichia coli; Etoposide; Female; Humans; Ifosfamide; Length of Stay; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Prednisolone; Treatment Outcome | 2018 |
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Lymphoma, Extranodal NK-T-Cell; Mitochondria; Resveratrol; Stilbenes | 2017 |
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cohort Studies; Dexamethasone; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Prognosis; Survival Analysis; Young Adult | 2018 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Middle Aged | 2018 |
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Prognosis; Risk; Survival Analysis | 2018 |
[Nasal NK/T-cell lymphoma: about two rare cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nasal Obstruction; Neoplasm Staging; Nose Neoplasms; Prednisolone; Prognosis; Vincristine | 2018 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid; Dexamethasone; Etoposide; Female; Headache; Humans; Ifosfamide; Lumbar Vertebrae; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Pia Mater; Polyradiculopathy | 2013 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; Cisplatin; Deoxycytidine; Dexamethasone; DNA, Viral; Etoposide; Gemcitabine; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Neoplastic Stem Cells; Nose Neoplasms; Ophthalmoplegia; Trigeminal Nerve Diseases; Viral Load | 2014 |
Orbital involvement by non-Hodgkin lymphoma NK T cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cytarabine; Ethmoid Sinus; Etoposide; Exophthalmos; Fatal Outcome; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinus; Methylprednisolone; Nasal Obstruction; Neoplasm Recurrence, Local; Orbit; Salvage Therapy; Tomography, X-Ray Computed | 2014 |
Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term fol
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2014 |
[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Treatment Outcome | 2014 |
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Dexamethasone; Etoposide; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Neoplasm Recurrence, Local; Treatment Outcome | 2014 |
Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrosp
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2015 |
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cohort Studies; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Young Adult | 2015 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisolone; Prognosis; Retrospective Studies; Young Adult | 2015 |
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Polyethylene Glycols; Retrospective Studies; Treatment Outcome | 2015 |
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Platinum Compounds; Radiation Dosage; Remission Induction; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Dexamethasone; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome | 2015 |
Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cisplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cytarabine; Dexamethasone; DNA Mutational Analysis; Etoposide; Female; Humans; Hydrocortisone; Hydroxamic Acids; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; MAP Kinase Kinase 1; Methotrexate; Mutation; Positive Regulatory Domain I-Binding Factor 1; Precision Medicine; Repressor Proteins; STAT3 Transcription Factor; Vorinostat | 2016 |
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prognosis; Transplantation, Homologous; Young Adult | 2016 |
[Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Effectiveness Research; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2016 |
Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Mesna; Methotrexate; Orbital Cellulitis; Paranasal Sinus Neoplasms; Prognosis; Treatment Outcome | 2016 |
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Japan; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Radiotherapy; Receptors, Interleukin-2; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2017 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagnosis; Dexamethasone; Diagnostic Errors; Etoposide; Fistula; Humans; Ifosfamide; Leucovorin; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinusitis; Methotrexate; Mouth Diseases; Nose Diseases; Nose Neoplasms; Palatal Neoplasms; Radiotherapy | 2017 |
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Substitution; Etoposide; Humans; Ifosfamide; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Methylprednisolone; Mycophenolic Acid; Postoperative Complications; Remission Induction; Tacrolimus; Transplant Recipients | 2017 |
[Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Liver Diseases; Lymphoma, Extranodal NK-T-Cell; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Orbital Neoplasms; Radiotherapy Dosage; Remission Induction; Time Factors; Treatment Outcome | 2009 |
Salvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal type.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Prednisone; Radiotherapy, Conformal; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2009 |
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone; Diagnosis, Differential; Disease Progression; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymph Nodes; Lymphatic Diseases; Lymphoma, Extranodal NK-T-Cell; Male; Radiography; Splenomegaly; Still's Disease, Adult-Onset; Treatment Outcome | 2009 |
Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transpl
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemotherapy, Adjuvant; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2010 |
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Child; Decitabine; DNA Methylation; DNA Modification Methylases; Down-Regulation; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; MicroRNAs; Middle Aged; NF-kappaB-Inducing Kinase; Prognosis; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Signal Transduction; TNF Receptor-Associated Factor 6; Treatment Outcome; Young Adult | 2011 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials, Phase II as Topic; Cohort Studies; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Young Adult | 2012 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose Neoplasms; Orchiectomy; Remission Induction; Skin; Testicular Neoplasms; Testis | 2013 |
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Doxorubicin; Etoposide; Facial Paralysis; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neurologic Examination; Omentum; Paraneoplastic Polyneuropathy; Spinal Nerve Roots; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2008 |